Clinical Trial Update: REDAPT Revision System Study to Assess 5 Year Revision Rate & up to 10 Year Revision Rate and Safety and Effectiveness

View source ↗

Summary

A clinical trial evaluating the REDAPT Revision System for total hip arthroplasty was withdrawn, with endpoints focused on long-term revision rates and safety/e…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Total Hip Arthroplasty

Drugs mentioned

• REDAPT Revision System

Snippet

Sponsor: Smith & Nephew, Inc. | Conditions: Total Hip Arthroplasty (THA) | Status: WITHDRAWN